MiraLax (polyethylene glycol) product image

Available to sourceHuman Prescription DrugGastrointestinal

PEG

Active ingredients · Polyethylene Glycol 3350, Potassium Chloride, Sodium Bicarbonate, Sodium Chloride

420 g/4L / 1.48 g/4L / 5.72 g/4L / 11.2 g/4L · Powder for Solution

By Wilshire Pharmaceuticals, Inc.

NDC: 52536-302
Route: Oral
Therapeutic class: Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative , Osmotic Laxative , Osmotic Laxative , Osmotic Laxative , Potassium Compounds [CS], Potassium Salt , Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]
Marketing category: NDA AUTHORIZED GENERIC

Package sizes

4 L in 1 BOTTLE (52536-302-01)NDC 52536-302-01Available to order

Additional information

Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.